Paul Thomen

Wednesday, 6 May 2015

Endometriosis Drug Analysis and Pipeline Review, H1 2015

This report provides comprehensive information on the therapeutic development for Endometriosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Endometriosis and special features on late-stage and discontinued projects.
Complete report on H1, 2015 Pipeline Review of “Endometriosis” addiction with 45 market data tables and 16 figures, spread across 127 pages is . (This is a premium report price at US$2000 for a single user PDF license)
Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
·         The report provides a snapshot of the global therapeutic landscape of Endometriosis
·         The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
·         The report reviews key players involved in the therapeutics development for Endometriosis and enlists all their major and minor projects
·         The report summarizes all the dormant and discontinued pipeline projects
·         A review of the Endometriosis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
·         Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
·         A detailed assessment of monotherapy and combination therapy pipeline projects
·         Coverage of the Endometriosis pipeline on the basis of target, MoA, route of administration and molecule type
Inquire for discount on this report at .
Reasons to Buy:
  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Endometriosis
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Endometriosis pipeline depth and focus of Indication therapeutics
2015 Market Research Report on Global Progesterone Industry
For international and China market analysis, the report analyzes Progesterone markets in China and other countries or regions (such as US, Europe, Japan, etc) by presenting research on global products of different types and applications, developments and trends of market, technology, competitive landscape, and leading suppliers’ and countries’ 2009-2014 capacity, production, cost, price, profit, production value, and gross margin. For leading suppliers, related information is listed as products, customers, application, capacity, market position, and company Contact information, etc. 2015-2020 forecast on capacity, production, cost, price, profit, production value, and gross margin for these markets are also included.
Complete report is available at .

No comments:

Post a Comment

Note: only a member of this blog may post a comment.